Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.
We examine injecting and sexual risk correlates of hepatitis B (HBV) and hepatitis C (HCV) seroprevalence among new injecting drug users (IDUs) (age 18-30 years, injecting < or =6 years). Participants were interviewed/serotested (HIVab, HBVcAb, HCVab) in New York City, February 1999-February 2003. Gender-stratified, multivariate logistic regression was conducted. Participants (N=259) were: 68% male; 81% white. Women were more likely to test HCV seropositive (42% versus 27%) and men HBV seropositive (24% versus 12%); HIV seroprevalence was low (3%). Among both men and women, HBV seropositivity was associated with ever selling sex, and HCV seropositivity with ever having had infected (HIV, HBV or HCV) sex partners (among those ever sharing injecting equipment). Among women only, HBV seropositivity was associated with ever having had infected sex partners (regardless of ever sharing injecting equipment), and HCV seropositivity with > or =300 lifetime drug injections. Among men only, HCV seropositivity was associated with > or =40 lifetime number of sex partners (among those never sharing injecting equipment). In this new IDU sample, HBV and HCV seroprevalence differed by gender and were considerably higher than HIV seroprevalence. Early interventions, targeting injecting and sexual risks and including HBV vaccination, are needed among new IDUs to prevent HBV, HCV and, potentially, HIV epidemics.
Neaigus
Alan
A
Institute for International Research on Youth at Risk, National Development and Research Institutes Inc., 71 West 23rd Street, New York City, NY 10010, USA. neaigus@ndri.org
Gyarmathy
V Anna
VA
Miller
Maureen
M
Frajzyngier
Vera
V
Zhao
Mingfang
M
Friedman
Samuel R
SR
Des Jarlais
Don C
DC
D000293:Adolescent; D000328:Adult; D015897:Comorbidity; D005260:Female; D015528:HIV Seroprevalence; D006306:Health Surveys; D006509:Hepatitis B / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D006526:Hepatitis C / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D008297:Male; D009519:New York City; D016036:Seroepidemiologic Studies; D011477:Sex Work / Q000706:statistics & numerical data; D012747:Sexual Partners; D013223:Statistics as Topic; D015819:Substance Abuse, Intravenous / Q000453:epidemiology*; D047568:Unsafe Sex; D014505:Urban Population / Q000706:statistics & numerical data*